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DObjective: Isolated pulmonary artery of ductal origin (IPADO) is a rare disease with diverse presentations.
Diagnostic and therapeutic approaches vary widely given the low incidence. Reporting additional cases may
help inform medical decision making.
Methods: We reviewed diagnostic data—including echocardiography, catheterization, and MRI—and out-
comes for all patients with IPADO at our institution.
Results: Thirty-seven patients who met inclusion criteria were identified. The mean age at diagnosis was 3
months (range, 1 day-45 years). In 11 patients, the duct supplying the IPADOwas patent (ie, patent ductus arterio-
sis [PDA]); the duct had closed (ligamentum) in the other 26 patients.When performed, catheterization delineated
the anatomy in 90% (100% if PDA) versus 54% with magnetic resonance imaging. Patients with a PDAwere
more likely to undergo intervention (100% vs 58%, P¼ .02) and had earlier first intervention (1 vs 20 months;
P<.001). Patients diagnosed at age6months were more likely to undergo intervention (86% vs 50%;P¼ .03)
and unifocalization (81% vs 44%; P¼ .04), and had greater IPADO flow at follow-up (40% vs 14%; P<.001).
Patients who underwent any intervention had greater IPADO flow than those without intervention (38% vs 0%).
Conclusions: Early IPADO diagnosis is important in long-term outcome. However, successful interventions can
be performed on older patients. Diagnosis relies on angiography but magnetic resonance imaging may play an
increasingly important role. Although initial intervention depends on individual factors, the ultimate goal should
be early unifocalization. (J Thorac Cardiovasc Surg 2014;148:2245-52)Ductal origin of a pulmonary artery (PA) is a rare condition.
Fraentzel1 published the first description of ‘‘a case of
abnormal communication of the aorta with the pulmonary
artery’’ in 1868. It is commonly associated with other
congenital heart diseases—mostly tetralogy of Fallot and
truncus arteriosus—with a prevalence up to 0.4%.2 This
lesion occurs in isolation as well, with an estimated inci-
dence of 1:200,000.3
When in isolation, this lesion is often described as a
unilaterally ‘‘absent’’ PA, but we prefer isolated PA of
ductal origin (IPADO), the descriptor used by Takatsuki
and colleagues.4 Although the extrapulmonary portion of
the PA is missing, the intrapulmonary vessels are present
and generally branch normally, suggesting the anomaly is
related to a specific embryologic disruption involving invo-
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The Journal of Thoracic and Carconnection persists between the intrapulmonary PA,
which arises from the respective lung bud, and the distal
sixth aortic arch, which develops into the ductus
arteriosus.8,9 The result is an intrapulmonary PA that is
discontinuous from the central pulmonary circulation and
fed directly by a ductus arteriosus (Figure 1).
IPADO presents in myriad ways, including recurrent infec-
tion, hemoptysis, pulmonary arterial hypertension (PAH),
congestive heart failure, and scoliosis; it affects some patients
severely at young ages, whereas others are asymptomatic with
serendipitous diagnosis in adulthood.10-12 Such heterogeneity
has been associated with variable approaches to management.
Treatment strategies include insertion of a surgical shunt to
promote IPADO growth before unifocalization into the
pulmonary circulation, unifocalizing the IPADO initially, or
performing an interventional catheterization before a
surgical intervention.13-16
Our aim was to provide data to help inform decision
making given this variation in practice. Although the inci-
dence of IPADO is insufficient to provide conclusive data,
we attempted to identify potentially relevant diagnostic
and therapeutic variables.PATIENTS AND METHODS
Patients
We performed a retrospective, single-center cohort study of all patients
with IPADO cared for at Boston Children’s Hospital. We included patients
with a patent foramen ovale, secundum atrial septal defect, or ventriculardiovascular Surgery c Volume 148, Number 5 2245
Abbreviations and Acronyms
IPADO ¼ isolated pulmonary artery of ductal origin
MPA ¼ main pulmonary artery
MRI ¼ magnetic resonance imaging
PA ¼ pulmonary artery
PAH ¼ pulmonary arterial hypertension
PDA ¼ patent ductus arteriosus
Congenital Heart Disease Batlivala et al
C
H
Dseptal defect that was deemed hemodynamically insignificant (ie, pressure
restrictive, no volume overload, and no intervention). Patients with a patent
ductus arteriosus (PDA) were also included given the integral relationship
between the ductus and IPADO. Exclusion criteria were cardiovascular le-
sions other than above, agenesis or severe hypoplasia of the ipsilateral lung,
and iatrogenic discontinuity of a PA (eg, after PDA ligation). Our study was
performed under a protocol approved by the Children’s Hospital Commit-
tee for Clinical Investigation, which included a waiver for requiring patient
consent.
Definitions and Outcomes
Nearly all patients underwent postoperative transthoracic echocardiog-
raphy andmany underwent nuclear scintigraphy lung perfusion and cardiac
magnetic resonance imaging (MRI) scans. All studies were performed for
clinical indications at the treating physician’s discretion. All data were ob-
tained from existing clinical records, with thorough attempts to obtain the
most recent data for patients treated outside our institution.
No study end points were defined a priori and the most recent data were
used for all patients. Study points of interest included age at first presenta-
tion and correct diagnosis, initial diagnosis or misdiagnosis, preoperative
catheterization or cardiac MRI (if performed), age at first intervention,
number and type of interventions (surgical: shunt or unifocalization; trans-
catheter: angioplasty or stenting), serious postprocedural complications,
death, and duration of follow-up. Serious postprocedural complications
included intra- or perioperative death and requirement for reintervention
within 15 days.
A shunt was defined as a surgically created connection between the
IPADO and systemic arterial system. Unifocalization was defined as a
connection of the IPADO to the PA circulation and further classified as
direct or with a tube graft. Direct unifocalization was anastomosis of the
IPADO directly to the main pulmonary artery (MPA), including use of
an MPA flap or noncircumferential piece of material to augment the anas-
tomosis. A tube graft was a fully circumferential tube of any material inter-
posed between the IPADO and MPA.
Study measures of interest included symptoms, history of PAH, treat-
ment with anti-PAH medications, initial and most recent percentage of
flow to the IPADO, and initial and most recent IPADO cross-sectional
area (indexed to body surface area). Two orthogonal measurements were
used to calculate cross-sectional area when available. PAH was defined
as a directly measured mean pressure 25 mm Hg in the PA continuous
with the right ventricle. If catheterization data were not available, PAH
was defined as an estimated right ventricle pressure 50% systemic by
echocardiographic measures. Catheterization and MRI adequately delin-
eated anatomy if at least 1 IPADO diameter and the distance from IPADO
to MPAwere reliably measured.
Data Analysis
Data are presented as median (range) or frequency (% of appropriate
cohort). Demographic, historical, diagnostic, and procedural variables
were compared between the cohorts. To detect associations, the population
was divided into 3 groups for comparisons: those who underwent any inter-
vention or not, status of the IPADO-supplying duct at presentation (PDA or2246 The Journal of Thoracic and Cardiovascular Surligamentum arteriosum), and age at presentation (6 vs>6 months). The
c2 or Fisher exact test were used to compare nominal variables between 2
or more groups. The Mann-Whitney U and Kruskal-Wallis tests were used
to compare medians between 2 or more groups. All data analyses and the
standard scatter plots were created using Statistical Package for the Social
Sciences software (version 19, IBM-SPSS Inc, Armonk, NY).RESULTS
Patients
We identified 49 patients with an IPADO managed at
Boston Children’s Hospital from July 1951 through
September 2011; 12 were excluded due to agenesis of the
ipsilateral lung or an iatrogenic IPADO. Demographic
and diagnostic variables of all patients are presented in
Table 1. Most patients presented in infancy with respiratory
symptoms, a murmur, or cyanosis. Two-thirds of the cohort
was diagnosed after 2000. Five patients were initially mis-
diagnosed; 2 were correctly diagnosed within 6 months,
whereas 3 were diagnosed 2, 3, and 20 years after presenta-
tion. All patients had an IPADO contralateral to aortic
sidedness, in keeping with the postulated etiology.8 Median
duration of follow-up data was 7.3 years.
Of 37 patients included in our study, 26 had an IPADO
connected to a ligamentum arteriosum, whereas 11 were
supplied by a PDA. Patients with a PDA presented earlier
(0.6 vs 4.3 months; P ¼ .04) and with shorter duration
from presentation to diagnosis (0.03 vs 1.6 months;
P< .001) than those with a ligamentum. More than half
of patients with a ligamentum presented with respiratory
symptoms, whereas most with a PDA presented with a
murmur or cyanosis. All patients presenting with hemopty-
sis had a ligamentum. Ductal status was not associated with
era (ie, diagnosis before or after January 1, 2000).
Twenty-one patients were diagnosed before age 6
months. Younger patients presented roughly equally with
respiratory symptoms, a murmur, or cyanosis, whereas
most older patients presented with respiratory symptoms.
No older patient presented with cyanosis. Both patients
with hemoptysis presented at older age (20 and 70 months).
Approximately 45% of younger patients had a PDA versus
only 12% of older patients. Younger patients were also
correctly diagnosed sooner after presentation (0.1 vs 4.8
months; P< .001) and had greater flow to the IPADO-
supplied lung initially (33% vs 0%; P<.001) (Figure 2).Diagnostic Studies
Nine PDA patients and 18 ligamentum patients under-
went preoperative catheterization. Catheterization
adequately delineated the anatomy in all cases with a
PDA, but in only 12 with a ligamentum; pulmonary vein
wedge angiograms were performed in all patients. Three
PDApatients and 10 ligamentumpatients had a preoperative
MRI. MRI adequately delineated anatomy in 1 PDA patientgery c November 2014
FIGURE 1. Simultaneous injections into a left isolated pulmonary artery
of ductal origin (IPADO) and right pulmonary artery. The right pulmonary
artery catheter courses antegrade through the right ventricle, whereas the
left IPADO catheter ascends retrograde from the right-sided aorta into
the left patent ductus arteriosus.
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Dand 6 ligamentum patients. No MRI defined the anatomy
when catheterization failed to do so.Therapeutic Strategies
Demographic, diagnostic, and therapeutic variables
based on initial intervention are presented in Table 2.
Twenty-six patients underwent at least 1 IPADO interven-
tion; all ultimately underwent surgery. Eight patients had
initial shunt placement, whereas 18 had initial unifocaliza-
tion. One of the shunt patients had initial transcatheter inter-
vention (PDA stent) with subsequent shunt palliation.
Another patient remains with a shunt with the plan to uni-
focalize; both patients currently with shunts have a left-
sided IPADO. The other 6 initial shunt patients underwent
subsequent unifocalization, all of which were with a tube
graft. Patients who had an initial unifocalization were
younger and underwent operation earlier than those with
initial shunt (Figure 3). Those patients also had fewer surgi-
cal interventions and fewer procedures overall.
Among unifocalized patients, 13 underwent direct uni-
focalization and 11 had tube grafts. The direct unifocaliza-
tion group was younger at diagnosis (0.7 vs 14 months;
P ¼ .001) and first intervention (1 vs 20 months;
P ¼ .003). The direct unifocalization group had fewer total
(2 vs 4; P¼ .01) and surgical (1 vs 2; P¼ .01) interventions
with more flow at most-recent follow-up (40% vs 32%).Reinterventions
A total of 40 postoperative interventions were performed
on 19 patients. Those procedures included 23 balloonThe Journal of Thoracic and Carangioplasties, 6 angioplasties with stent placement, and
11 operations. All 8 shunt patients had a postoperative inter-
vention; 5 of the 8 had a first reintervention related to issues
with the shunt (ie, anastomotic stenosis or shunt throm-
bosis), whereas 3 had unifocalization at first reintervention.
Of the 18 patients initially unifocalized, 7 had no reinter-
ventions. Among the 11 with reinterventions, 1 had a reop-
eration for acute thrombosis of a unifocalized tube graft and
10 patients only had catheter-based reinterventions. The
median duration to first reintervention was longer in the
initially unifocalized group (5 vs 2.4 months) with fewer re-
interventions performed per subject (1 vs 2).
Outcomes
All patients with a PDA underwent an intervention versus
only 58% of patients with a ligamentum. Younger patients
had greater IPADO flow at recent measurement (40% vs
14%; P< .001). Younger patients were also more likely
to undergo intervention (86% vs 50%) and to undergo ulti-
mate unifocalization (81% vs 44%) (Figure 2).
Among 16 patients who presented after age 10 months, 8
underwent intervention. Patients who underwent interven-
tion were younger (median 31 vs 165 months; P ¼ .03),
the oldest of whom was diagnosed at 83 months. Of these
8, 2 had a PDA and 6 had a ligamentum. One of the patients
with a PDA had direct unifocalization and had an increase
in IPADO flow from 0% to 16%. The other patient with a
PDA underwent initial catheter-based PDA stenting fol-
lowed by shunt placement; the shunt thrombosed, no subse-
quent interventions were performed, and there was no flow
to the IPADO at most recent follow-up. Two patients with a
ligamentum were initially unifocalized with increases in
flow from 0% to 28% and 30%. The other 4 patients had
initial shunt placement followed by unifocalization; 1 had
a minimal increase in flow but 2 had final indexed IPADO
flows of 14% and 15% and the other had an increase in
IPADO area from 12 to 40 mm2/m2.
Complications
Four patients experienced serious postoperative complica-
tions: 3 had thrombosis of a shunt and 1 had thrombosis of a
unifocalization tube graft. Two of the shuntswere completely
occluded and replaced; 1 was restored with thrombectomy.
The shunt thrombectomy patient had partial thrombosis, sig-
nificant lung disease with PAH, and died shortly after. Of the
2 patients with complete shunt occlusion, 1 had the smallest
indexed cross-sectional area of the entire cohort and the other
was well below the median. The patient with tube graft
thrombosis underwent graft replacement on postoperative
day 5 with no further complications.
Three known deaths occurred that were related, at least in
part, to the IPADO. Two had been correctly diagnosed
initially, but both patients were born prematurely with sig-
nificant lung disease. One died from sepsis in infancy anddiovascular Surgery c Volume 148, Number 5 2247
TABLE 1. Demographic, diagnostic, and follow-up data for the entire population and by cohort
All patients (N ¼ 37) Any intervention (n ¼ 26) No intervention (n ¼ 11) P value*
Discontinuous PA
Left 17 (46%) 12 (46%) 5 (45%)
Right 20 (54%) 14 (54%) 6 (55%)
Age at diagnosis, mo 3.2 (0-539) 2.4 (0-83.5) 66.2 (0.1-539) .01
Era of diagnosis .008
Before January 1, 2000 12 (32%) 5 (19%) 7 (64%)
On or after January 1, 2000 25 (68%) 21 (81%) 4 (36%)
Sex
Male 15 (41%) 11 (42%) 4 (36%)
Female 22 (49%) 15 (58%) 7 (64%)
Status of duct at diagnosis .01
Patent 11 (30%) 11 (42%) 0 (0%)
Ligamentum 26 (70%) 15 (58%) 11 (100%)
Age of presenting complaint, mo 2.3 (0-516) 1.5 (0-69) 5.2 (0-516)
Presenting symptom/sign
Respiratory symptoms 15 (41%) 10 (38%) 5 (45%)
Murmur 10 (27%) 7 (27%) 3 (27%)
Cyanosis 6 (16%) 4 (15%) 2 (18%)
Hemoptysis 2 (5%) 2 (8%) 0 (0%)
Othery 4 (11%) 3 (12%) 1 (9%)
Initial misdiagnoses 5 (14%) 2 (8%) 3 (27%)
Time from presentation to diagnosis, mo 1 (0-244) 0.4 (0-34) 3.4 (0.1-244) .01
Right ventricular hypertension
At time of diagnosis 19 (51%) 11 (42%) 8 (73%)
Ever 22 (59%) 14 (52%) 8 (73%)
At most recent follow-up 8 (22%) 1 (4%) 7 (64%) <.001
Pulmonary antihypertensive medications
Ever 4 (11%) 2 (8%) 2 (18%)
At most recent follow-up 2 (5%) 1 (4%) 1 (9%)
Symptoms at most recent follow-up 6 (16%) 2 (8%) 4 (36%) .03
Age at first intervention, mo 4.5 (0.1-91.6) NA
First intervention type
Surgical 25 (96%) NA
Transcatheter 1 (4%) NA
First operation
Shunt 8 (31%) NA
Unifocalization 18 (69%) NA
Total interventions 2 (1-6) NA
Total surgical interventions 1 (1-3) NA
Ultimately unifocalized 24 (92%) NA
Age at unifocalization, mo 4.9 (0.1-97) NA
Initial IPADO cross-sectional area
Indexed, mm2/m2 17.5 (0-69.1) 24.6 (6.6-69.1) 0 (0-5) <.001
Most recent IPADO cross-sectional area
Indexed, mm2/m2 50.6 (0-189) 53.3 (23.7-189) 0 (0-0) .1
First flow distribution to IPADO,% 11 (0-59) 15 (0-59) 0 (0-1) .04
Most recent flow distribution to IPADO,% 34 (0-59) 38 (0-59) 0 (0-1) .008
Duration of follow-up, y 7.3 (0.1-59) 7.4 (0-20) 6.5 (2-59)
Data are presented as median (range) or frequency (%). PA, Pulmonary artery; NA, not applicable; IPADO, isolated pulmonary artery of ductal origin. *Comparing any inter-
vention and no intervention cohorts. yOther diagnoses include abnormal chest radiograph, electrocardiogram, and screening obstetric ultrasound.
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ative shunt occlusion. The third patient was diagnosed with
IPADO at age 44 years after an MRI, and ultimately died
from heart failure related to PAH at age 60 years.2248 The Journal of Thoracic and Cardiovascular SurDISCUSSION
Importance of Age at Intervention and Outcome
Many studies have suggested that early diagnosis and
management of patients with IPADO is important.17-20gery c November 2014
FIGURE 2. Scatter plots comparing first measured indexed isolated pul-
monary artery of ductal origin (IPADO) cross-sectional area (CSA). A,
Most recent indexed IPADOCSA. B, Most recent flow to the IPADO based
on age and presence of right ventricle (RV) hypertension at most recent
follow-up. Circles indicate diagnosed at age<6 mo, triangles indicate
diagnosed at age 6 mo. No fill indicates normal right ventricle pressure
at most recent follow-up, solid fill indicates right ventricle hypertension
at most recent follow-up. *Percent flow to IPADO is expressed as percent
of total pulmonary blood flow.
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pulmonary flow distribution as close to normal as possible
should be the primary treatment goals. In our cohort,
patients diagnosed earlier were more likely to undergo
unifocalization, suggesting that age at diagnosis is
important. Interestingly, we did not observe an association
between age and the total number of interventions
performed. This may be due to the heterogeneity in
presentation and therapeutic strategies. Also, older
patients may have vascular disease in the affected lung,
precluding aggressive attempts to rehabilitate the IPADO.
We also did not observe differences in complication ratesThe Journal of Thoracic and Carbetween cohorts based on age, suggesting the risk of
intervention is not necessarily greater in younger patients.
Most patients, even those diagnosed after age 10 months,
had reasonable improvement in IPADO flow and area,
especially when unifocalized. Overall, we believe that
diagnosis and intervention before age 6 months should be
a primary goal, but that patients of any age can yield
benefit from unifocalization.Associations With Initial Ductal Status
Our data demonstrate that patients with a PDA have po-
tential advantages compared with those in whom the ductus
has closed. Patients with a PDA presented at an earlier age
and were diagnosed more rapidly; 9 of 11 were diagnosed
before age 4 months and 5 were diagnosed as neonates
(the oldest patient was aged 49 months and an outlier).
This association of age and ductal status may be related to
the fact that many PDA patients presented with murmurs
in early infancy, likely leading to evaluation by a pediatric
cardiologist. Also, fewer PDA patients presented with
recurrent respiratory symptoms or infections compared
with patients with a ligamentum. This nonspecific presenta-
tion may have led to more extensive evaluation in ligamen-
tum patients before referral to a cardiologist, prolonging
time to diagnosis. In fact, half the ligamentum patients
were diagnosed after 1 year, with the oldest diagnosed at
nearly 45 years of age; again, ductal status was not associ-
ated with era of diagnosis. We further speculate that this
later diagnosis may be related to the development of he-
moptysis. Although hemoptysis is incompletely understood
in patients with congenital cardiac disease, prolonged diag-
nosis may lead to the development of increased pulmonary
vascular resistance and systemic-to-pulmonary collaterals
that may play a role in this phenomenon.10,21,22 Several
studies have described the deleterious consequences of a
delay in diagnosis.17,23 Our data corroborate this, because
nearly one-third of patients with a ligamentum had PAH
at most recent follow-up.Therapeutic Strategies
Therapeutic strategies in this series fell into 2 basic ap-
proaches: shunt placement followed by direct unifocaliza-
tion and direct unifocalization initially.24 Krammoh and
colleagues16 espoused a variant of the first strategy, recom-
mending initial stenting of the PDA supplying the IPADO
with subsequent unifocalization. They hypothesized that
increased flow would improve the technical feasibility and
success of unifocalization. They believed this was espe-
cially useful in patients with hypoplastic branch PAs,
because small PAs lead to greater pulmonary vascular resis-
tance with a higher propensity for thrombosis of a surgical
shunt. Conversely, other authors have postulated that the
optimal strategy is direct unifocalization as early asdiovascular Surgery c Volume 148, Number 5 2249
TABLE 2. Demographic, diagnostic, and follow-up data based on initial surgical intervention
Variable Shunt (n ¼ 8) Unifocalization (n ¼ 18) P value
Discontinuous PA
Left 5 (62.5%) 11 (61%)
Right 3 (37.5%) 7 (39%)
Age at diagnosis, mo 22.9 (1.5-83.5) 0.8 (0-49.9) .001
Era of diagnosis .13
Before January 1, 2000 0 (0%) 5 (28%)
On or after January 1, 2000 8 (100%) 13 (72%)
Status of duct at diagnosis .23
Patent 2 (25%) 9 (50%)
Ligamentum 6 (75%) 9 (50%)
Right ventricular hypertension
At time of diagnosis 1 (17%) 10 (56%)
Ever 3 (50%) 11 (61%)
At most recent follow-up 0 (0%) 1 (6%)
First intervention
Surgery 7 (87.5%) 18 (100%)
Catheterization 1 (12.5%) 0 (0%)
Age at first operation, mo 35.5 (2.8-91.6) 2.4 (0.1-58.1) .003
Subsequent unifocalization 6 (75%) NA
Time from shunt to unifocalization 5.6 (2.6-28.3) NA
Any intervention(s) after first operation 8 (100%) 11 (61%) .048
Total interventional catheterizations per patient
Balloon dilation 1.5 (0-2) 1 (0-3)
Stent placement 0 (0-0) 0 (0-2)
Duration from surgery to first reintervention, mo 2.4 (0.1-5.5) 5 (0.2-46.7) .07
Total surgical interventions per patient 2 (1-3) 1 (1-3) <.001
Total interventions per patient 3.5 (2-5) 2 (1-4) .02
Age at unifocalization, mo 39 (10.4-97) 2.4 (0.1-58.1) .001
Initial IPADO cross-sectional area
Indexed, mm2/m2 13.2 (6.6-26) 32.9 (9.5-69.1) .14
Most recent IPADO cross-sectional area <.001
Indexed, mm2/m2 40.1 (25.2-189) 71.7 (23.7-171.4)
First flow distribution to IPADO,% 7 (0-41) 22 (0-59) .25
Most recent flow distribution to IPADO,% 14 (0-41) 40 (16-59) <.001
Duration of follow-up, y 4.2 (0.9-10.4) 8.5 (0.1-20)
Data are presented as median (range) or frequency (%). PA, Pulmonary artery; NA, not applicable; IPADO, isolated pulmonary artery of ductal origin.
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augment IPADO growth.18
Patients who underwent initial unifocalization in our
cohort had superior outcomes (Figure 4). Multiple factors
may explain this observation, some of which may be related
to intrinsic pathophysiology and others to the specific ther-
apy. One issue is that patients who underwent shunt place-
ment were older and more likely to have a ligamentum. It is
plausible that those patients had more hypoplastic or
dysplastic pulmonary vasculature, impeding flow and
growth of the IPADO. Earlier unifocalization should best
restore normal PA physiology and may allow the IPADO
and distal vasculature to match somatic growth.
It has been hypothesized that unifocalization technique
is relevant.25,26 Our data suggest that patients with direct
unifocalization have superior outcomes to those with an
interposition graft. Other authors have described this
association.18,19 One explanation is that tube grafts do2250 The Journal of Thoracic and Cardiovascular Surnot grow, thereby impeding flow, IPADO growth, and
normal vascular arborization in the long term. They
may also require more PA interventions to maintain
optimal IPADO growth. However, 9 of 11 tube graft
patients had a ligamentum and all had initial shunt
placement, possibly confounding this association.
Overall, we believe that direct unifocalization is the
preferred therapeutic goal.
Direct Angiography Versus MRI
The diagnostic standard for defining IPADO anatomy has
been angiography. As its role increases, MRI’s ability to
delineate anatomy has been questioned, especially if the
duct is atretic or closing.27 Other authors have argued that
evolving imaging techniques address this issue.28 Our
data confirm that angiography can delineate the anatomy,
especially if the duct is patent. Although not 100%
sensitive, pulmonary venous wedge angiography isgery c November 2014
FIGURE 3. Scatter plot comparing age at presentation and most recent flow to the isolated pulmonary artery of ductal origin (IPADO) based on initial
operation and status of the IPADO at diagnosis. Circles indicate patent ductus arteriosus (PDA) at diagnosis, triangles indicate ligamentum at diagnosis.
No fill indicates initial shunt, solid fill indicates initial unifocalization. *Percent flow to IPADO is expressed as percent of total pulmonary blood flow.
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MRI failed to delineate the anatomy when catheterization
was unsuccessful in our experience. However, MRI delin-
eated the anatomy in 60% of patients with a ligamentum.
Although our sample size is small, the utility of MRI in
patients with ligamentum should not be overlooked.FIGURE 4. Bar graphs comparing patients who underwent unifocalization ve
artery of ductal origin; RV, right ventricle.
The Journal of Thoracic and CarLimitations
Our study has numerous limitations. It was a retrospec-
tive, single center study with a small sample size. In addi-
tion, there was significant heterogeneity in diagnostic and
therapeutic strategies. Furthermore, no strict criteria were
developed. Lastly, we had limited statistical capability sorsus those who did not. *Significant P value. IPADO, Isolated pulmonary
diovascular Surgery c Volume 148, Number 5 2251
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Dage, PDA, era, and other variables had potentially con-
founding effects.CONCLUSIONS
IPADO is a rare condition that presents in a variety of
ways, with significant consequences, including impaired
lung growth, PAH, and hemoptysis. Early diagnosis and
intervention appear to be important to optimize long-
term outcomes. We recommend a therapeutic strategy
with initial catheterization or MRI to adequately delineate
the anatomy and the ultimate goal of IPADO unifocaliza-
tion as early as possible. A preceding procedure to in-
crease flow to the IPADO may be warranted, but should
be undertaken cautiously in patients with a small IPADO
or PAH. Close follow-up with transcatheter interventions
to augment IPADO growth as indicated may lead to
optimal outcomes.References
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